Inpatient vs. elective outpatient cardiac resynchronization therapy device implantation and long-term clinical outcome

Europace

Volumn 12, Issue 12, 2010, Pages 1745-1749

  Ajijola, Olujimi A ^a   MacKlin, Eric A ^a   Moore, Stephanie A ^a   McCarty, David ^a   Bischoff, Kara E ^a   Heist, Edwin Kevin ^a   Picard, Michael ^a   Ruskin, Jeremy N ^a   William Dec, George ^a   Singh, Jagmeet P ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cardiac resynchronization therapy; Clinical outcomes; Heart failure; Pacing

Indexed keywords

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; COMORBIDITY; CONTROLLED STUDY; DEFIBRILLATOR; DIABETES MELLITUS; ELECTIVE SURGERY; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE; HEART TRANSPLANTATION; HEART VENTRICLE FUNCTION; HOSPITAL PATIENT; HUMAN; IMPLANTATION; KIDNEY FAILURE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTPATIENT; PRIORITY JOURNAL; PROGNOSIS; RISK; SYNCOPE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; COHORT STUDIES; COMORBIDITY; DIABETES MELLITUS; FEMALE; HEART FAILURE; HUMANS; INPATIENTS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; OUTPATIENTS; PROGNOSIS; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 78649337915     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euq319     Document Type: Article

References (13)

1. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E et al. MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation. Cardiac resyn-chronization in chronic heart failure. N Engl J Med 2002;346:1845-53.
2. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T et al. Compari-son ofMedical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapywith orwithout an implantable defi-brillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50.
3. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C et al. Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multi-site biventricular pacing in patients with heart failure and intraventricular conduc-tion delay. N Engl J Med 2001;344:873-80.
4. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al. Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-49.
5. Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J et al. Results of the predictors of response to CRT (PROSPECT) trial. Circulation 2008;117: 2608-16.
6. Jurcut R, Pop I, Calin C, Coman IM, Ciudin R, Ginghina C. Utility of QRS width and echocardiography parameters in an integrative algorithm for selecting heart failure patients with cardiac dyssynchrony. Eur J Intern Med 2009;20:213-20.
7. Hawkins NM, Petrie MC, Burgess MI, McMurrayJJ. Selecting patients for cardiac resynchronization therapy: the fallacy of echocardiographic dyssynchrony. J Am Coll Cardiol 2009;53:1944-59.
8. Ahmed MI, White M, Ekundayo OJ, Love TE, Aban I, Liu B et al. A history of atrial fibrillation and outcomes in chronic advanced systolic heart failure: a propensity-matched study. Eur Heart J 2009;30:2029-37.
9. Tribouilloy C, Lévy F, Rusinaru D, Guéret P, Petit-Eisenmann H, Baleynaud S et al. Outcome after aortic valve replacement for low-flow/low-gradient aortic stenosis without contractile reserve on dobutamine stress echocardiography. J Am Coll Cardiol 2009;53:1865-73.
10. Bai R, Di Biase L, Elayi C, Ching CK, Barrett C, Philipps K et al. Mortality of heart failure patients after cardiac resynchronization therapy: identification of predic-tors. J Cardiovasc Electrophysiol 2008;19:1259-65.
11. Mangiavacchi M, Gasparini M, Genovese S, Pini D, Klersy C, Bragato R et al. Insulin-treated type 2 diabetes is associated with a decreased survival in heart failure patients after cardiac resynchronization therapy. Pacing Clin Electrophysiol 2008;31:1425-32.
12. Hoppe UC, Freemantle N, Cleland JG, Marijianowski M, Erdmann E. Effect of cardiac resynchronization on morbidity and mortality of diabetic patients with severe heart failure. Diabetes Care 2007;30:722-4.
13. Soliman OI, van Dalen BM, Theuns DA, Ten Cate FJ, Nemes A,Jordaens LJ et al. The ischemic etiology of heart failure in diabetics limits reverse left ventricular remodeling after cardiac resynchronization therapy. J Diabetes Complications 2009;23:365-70.